OCGN
Price
$1.50
Change
+$0.13 (+9.49%)
Updated
Jun 26 closing price
Capitalization
502.7M
34 days until earnings call
Intraday BUY SELL Signals
QSI
Price
$0.85
Change
-$0.01 (-1.16%)
Updated
Jun 26 closing price
Capitalization
185.86M
44 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

OCGN vs QSI

OCGN vs QSI Comparison Chart in %
View a ticker or compare two or three
VS
OCGN vs. QSI commentary
Jun 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCGN is a Buy and QSI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2026
Stock price -- (OCGN: $1.49 vs. QSI: $0.85)
Brand notoriety: OCGN and QSI are both not notable
OCGN represents the Biotechnology, while QSI is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: OCGN: 674% vs. QSI: 274%
Market capitalization -- OCGN: $502.7M vs. QSI: $185.86M
OCGN [@Biotechnology] is valued at $502.7M. QSI’s [@Medical/Nursing Services] market capitalization is $185.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $163.94B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCGN’s FA Score shows that 0 FA rating(s) are green whileQSI’s FA Score has 0 green FA rating(s).

  • OCGN’s FA Score: 0 green, 5 red.
  • QSI’s FA Score: 0 green, 5 red.
According to our system of comparison, both OCGN and QSI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCGN’s TA Score shows that 5 TA indicator(s) are bullish while QSI’s TA Score has 2 bullish TA indicator(s).

  • OCGN’s TA Score: 5 bullish, 5 bearish.
  • QSI’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, OCGN is a better buy in the short-term than QSI.

Price Growth

OCGN (@Biotechnology) experienced а +19.76% price change this week, while QSI (@Medical/Nursing Services) price change was -14.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.08%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was +1916.03%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.65%. For the same industry, the average monthly price growth was -0.04%, and the average quarterly price growth was -13.16%.

Reported Earning Dates

OCGN is expected to report earnings on Jul 31, 2026.

QSI is expected to report earnings on Aug 10, 2026.

Industries' Descriptions

@Biotechnology (+4.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical/Nursing Services (+2.65% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCGN($503M) has a higher market cap than QSI($186M). OCGN YTD gains are higher at: 10.000 vs. QSI (-22.409). OCGN has higher annual earnings (EBITDA): -64.04M vs. QSI (-91.54M). QSI has more cash in the bank: 127M vs. OCGN (31.9M). QSI has less debt than OCGN: QSI (3.71M) vs OCGN (33.3M). OCGN has higher revenues than QSI: OCGN (4.47M) vs QSI (1.85M).
OCGNQSIOCGN / QSI
Capitalization503M186M270%
EBITDA-64.04M-91.54M70%
Gain YTD10.000-22.409-45%
P/E RatioN/AN/A-
Revenue4.47M1.85M241%
Total Cash31.9M127M25%
Total Debt33.3M3.71M897%
FUNDAMENTALS RATINGS
OCGN: Fundamental Ratings
OCGN
OUTLOOK RATING
1..100
35
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
3

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OCGNQSI
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend about 1 month ago
79%
Declines
ODDS (%)
Bearish Trend 18 days ago
87%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
OCGN
Daily Signal:
Gain/Loss:
QSI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBMTX16.11N/A
N/A
Neuberger Mid Cap Growth Tr
IPFCX33.63N/A
N/A
Poplar Forest Cornerstone Investor
ALMCX8.21N/A
N/A
Alger Weatherbie Specialized Growth C
OGLCX67.89N/A
N/A
Invesco Global C
DDERX16.78-0.05
-0.30%
Nomura Wealth Builder R6

OCGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCGN has been loosely correlated with RAIN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if OCGN jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCGN
1D Price
Change %
OCGN100%
+8.39%
RAIN - OCGN
53%
Loosely correlated
-3.50%
ARRY - OCGN
47%
Loosely correlated
-7.41%
AXON - OCGN
46%
Loosely correlated
+4.52%
BEAM - OCGN
40%
Loosely correlated
+2.52%
QSI - OCGN
38%
Loosely correlated
-0.44%
More

QSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, QSI has been loosely correlated with PACB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if QSI jumps, then PACB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QSI
1D Price
Change %
QSI100%
-0.44%
PACB - QSI
52%
Loosely correlated
+3.12%
AXON - QSI
49%
Loosely correlated
+4.52%
VCYT - QSI
47%
Loosely correlated
+3.13%
BFLY - QSI
43%
Loosely correlated
+10.85%
MESO - QSI
39%
Loosely correlated
-9.03%
More